Aparna Keshaviah
Health

Aparna Keshaviah

Principal Researcher; Director of Wastewater Research

Aparna Keshaviah is a nationally recognized expert in the field of wastewater-based epidemiology and has two decades of experience bringing advanced analytics and innovative data sources to clarify urgent public health questions.

She works with agencies and organizations to develop alerts, risk scores, and translational metrics that further the use and interpretation of wastewater and other health data, to provide communities with an efficient and cost-effective way to monitor the health of their populations.

Keshaviah also directs research at the intersection of population health and environmental health. Leveraging her expertise in data visualization, she has developed digital tools designed to strengthen community preparedness and response to infectious diseases and extreme weather events, such as heat waves. Her work aims to help clinicians, patients, and communities recognize and address adverse health effects.

Before joining Mathematica, Keshaviah led the design and analysis of clinical trials at the Dana-Farber Cancer Institute, where she conducted head-to-head comparisons of the safety and efficacy of cancer treatments to support clinical decision making around breast cancer treatments. While at Massachusetts General Hospital, she directed clinical research on a range of mental health conditions, analyzing patient symptom profiles to evaluate the effectiveness of psychiatric interventions. Her research has been profiled in The New York Times and CNN and published in journals such as the New England Journal of MedicineProceedings of the National Academies of Sciences, and Environmental Health Perspectives. She is a 2006–2007 Fulbright fellow and holds a master’s degree in biostatistics from the Harvard School of Public Health.

Expertise
  • Wastewater surveillance
  • Translational research
  • Data visualization
  • Statistical modeling
  • Survey design
Focus Area Topics
  • Health
  • Population Health
  • Energy
  • COVID-19
  • Mental Health and Substance Use